INSM Q3 2021 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$30B

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$47M+7.1% YoY

Gross Profit

$37M78.2% margin

Operating Income

-$104M-221.6% margin

Net Income

-$113M-241.1% margin

EPS (Diluted)

$-0.96

QoQ Revenue Growth

+3.1%

Cash Flow

Operating Cash Flow

-$75M

Free Cash Flow

-$77M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$807M

Stockholders' Equity

$505M

Cash & Equivalents

$847M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$47M	$44M	+7.1%
Gross Profit	$37M	$33M	+10.8%
Operating Income	-$104M	-$56M	-84.3%
Net Income	-$113M	-$64M	-77.1%